Your browser doesn't support javascript.
loading
CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure.
Huang, Chenlu; Li, Weixia; Chen, Chong; Xu, Wei; Fei, Ling; Tao, Shuai; Hu, Qiankun; Xie, Xudong; Cao, Xiongyue; Zhang, Xiao-Yu; Chen, Liang; Li, Qiang; Huang, Yuxian.
Afiliação
  • Huang C; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Li W; Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Chen C; Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Xu W; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Fei L; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Tao S; Research Unit, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Hu Q; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Xie X; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Cao X; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Zhang XY; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Chen L; Section of Education, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Li Q; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
  • Huang Y; Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China.
J Inflamm Res ; 16: 197-207, 2023.
Article em En | MEDLINE | ID: mdl-36660376

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Inflamm Res Ano de publicação: 2023 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Inflamm Res Ano de publicação: 2023 Tipo de documento: Article País de publicação: Nova Zelândia